StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pure Bioscience's price to sales ratio was 3.7× on Oct 19, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 2.0× to 12.3×, with a median of 5.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20263.7×+1.7
2025Dec 31, 20252.0×−2.0
2024Dec 31, 20244.0×−2.9
2023Dec 29, 20236.9×+1.9
2022Dec 30, 20225.0×−1.0
2021Dec 31, 20216.0×−2.5
2020Dec 31, 20208.6×−5.0
2019Dec 31, 201913.5×−0.8
2018Dec 31, 201814.3×−22.3
2017Dec 29, 201736.6×+2.1
2016Dec 30, 201634.5×−31.9
2015Dec 31, 201566.4×+27.5
2014Dec 31, 201438.9×+5.7
2013Dec 31, 201333.3×+23.0
2012Dec 31, 201210.2×−9.2
2011Dec 30, 201119.5×–

More Pure Bioscience figures

See a number that looks wrong?